(11bR,11'bR)-4,4'-(1S,2S)-1,2-cyclohexanediylbis[4,5-dihydro-H-Dinaphth[2,1-c:1',2'-e]azepine

Englisch Name:: (11bR,11'bR)-4,4'-(1S,2S)-1,2-cyclohexanediylbis[4,5-dihydro-H-Dinaphth[2,1-c:1',2'-e]azepine

Synonyma:: (11BR,11'bR)-(1S,2S)-1,2-bis(3,5-dihydro-4H-dinaphtho[2,1-c:1',2'-e]azepin-4-yl)cyclohexane;(11bR,11'bR)-4,4'-(1S,2S)-1,2-cyclohexanediylbis[4,5-dihydro-H-Dinaphth[2,1-c:1',2'-e]azepine;(11bR,11'bR)-4,4'-(1S,2S)-1,2-cyclohexanediylbis[4,5-dihydro-H-Dinaphth[2,1-c:1',2'-e]azepine;(11bR,11'bR)-4,4'-(1S,2S)-1,2-Cyclohexanediylbis[4,5- dihydro-3H-dinaphth[2,1-c:1',2'-e]azepine;3H-Dinaphth[2,1-c:1′,2′-e]azepine, 4,4′-(1S,2S)-1,2-cyclohexanediylbis[4,5-dihydro-, (11bR,11′bR)-;(11bR,11'bR)-4,4'-(1S,2S)-1,2-Cyclohexanediylbis[4,5- dihydro-3H-dinaphth[2,1-c:1',2'-e]azepine,99%e.e.;3H-Dinaphth[2,1-c:1',2'-e]azepine, 4,4'-(1S,2S)-1,2-cyclohexanediylbis[4,5-dihydro-, (11bR,11'bR)- (9CI)

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 7

(11bR,11'bR)-4,4'-(1S,2S)-1,2-cyclohexanediylbis[4,5-dihydro-H-Dinaphth[2,1-c:1',2'-e]azepine Eigenschaften

Global( 7)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Daicel Chiral Technologies (China)CO.,LTD	021-50460086-9 15921403865	han_yajun@dctc.daicel.com	China	7195	65
Tianjin Derchemist Science & Technology Co., Ltd.	22-58627059 13920586291	zdcomcon@126.com	China	3461	50
Greenherbs Science and Technology Development Co., Ltd.	010-61136123	pub02@greenherbs.com.cn	China	4049	58
Shanghai Anyinuo Biomedical Technology Co., Ltd.	021-34625901	420970979@qq.com	China	5783	58
Jinan ponder chemical co. LTD	0531-0000	thinklifescience@163.com	China	19689	58
Taizhou Nanfeng Pharmaceutical Research Institute	18616377689	nanfengdrug@163.com	China	20000	58
Energy Chemical	021-58432009 400-005-6266	marketing@energy-chemical.com	China	44918	58

(11bR,11'bR)-4,4'-(1S,2S)-1,2-cyclohexanediylbis[4,5-dihydro-H-Dinaphth[2,1-c:1',2'-e]azepine
(11bR,11'bR)-4,4'-(1S,2S)-1,2-Cyclohexanediylbis[4,5- dihydro-3H-dinaphth[2,1-c:1',2'-e]azepine
(11bR,11'bR)-4,4'-(1S,2S)-1,2-Cyclohexanediylbis[4,5- dihydro-3H-dinaphth[2,1-c:1',2'-e]azepine,99%e.e.
3H-Dinaphth[2,1-c:1',2'-e]azepine, 4,4'-(1S,2S)-1,2-cyclohexanediylbis[4,5-dihydro-, (11bR,11'bR)- (9CI)
(11BR,11'bR)-(1S,2S)-1,2-bis(3,5-dihydro-4H-dinaphtho[2,1-c:1',2'-e]azepin-4-yl)cyclohexane
3H-Dinaphth[2,1-c:1′,2′-e]azepine, 4,4′-(1S,2S)-1,2-cyclohexanediylbis[4,5-dihydro-, (11bR,11′bR)-
(11bR,11'bR)-4,4'-(1S,2S)-1,2-cyclohexanediylbis[4,5-dihydro-H-Dinaphth[2,1-c:1',2'-e]azepine
524941-64-8
C50H42N2